These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 16967810

  • 1. Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.
    Anwarul Islam AK, Kashem MA, Shameem IA, Kibria SA.
    Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):54-61. PubMed ID: 16967810
    [Abstract] [Full Text] [Related]

  • 2. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.
    Keetch DW, Andriole GL, Ratliff TL, Catalona WJ.
    Urology; 1997 Dec; 50(6):901-5. PubMed ID: 9426721
    [Abstract] [Full Text] [Related]

  • 3. [Clinical effectiveness and safety study of combined therapy with an alpha-blocker and an anticholinergic for patients with LUT/BPH].
    Xiao H, Li HZ, Yang Y, Huang ZM, Li YQ, Zhao XF.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 19; 87(23):1590-3. PubMed ID: 17803845
    [Abstract] [Full Text] [Related]

  • 4. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ, Guo YL, Gu FL.
    J Med; 1998 Jun 19; 29(5-6):289-304. PubMed ID: 10503165
    [Abstract] [Full Text] [Related]

  • 5. Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
    Tsai YS, Lan SK, Ou JH, Tzai TS.
    Clin Ther; 2007 Apr 19; 29(4):670-82. PubMed ID: 17617290
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi M, Narayan P, Padley RJ.
    N Engl J Med; 1996 Aug 22; 335(8):533-9. PubMed ID: 8684407
    [Abstract] [Full Text] [Related]

  • 7. Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.
    Lowe FC, McDaniel RL, Chmiel JJ, Hillman AL.
    Urology; 1995 Oct 22; 46(4):477-83. PubMed ID: 7571214
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y, Zhao XF, Li HZ, Wang W, Zhang Y, Xiao H, Zhang X.
    Chin Med J (Engl); 2007 Mar 05; 120(5):370-4. PubMed ID: 17376305
    [Abstract] [Full Text] [Related]

  • 9. [Efficiency and tolerance of terazosine in ambulatory patients with benign prostatic hypertrophy: comparative randomized and double-blind trial versus alfuzosin. The MG Terazosine Group].
    Fourcade RO.
    Prog Urol; 2000 Apr 05; 10(2):246-53. PubMed ID: 10857142
    [Abstract] [Full Text] [Related]

  • 10. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H, Williford WO, Barry MJ, Haakenson C, Jones K.
    J Urol; 1998 Oct 05; 160(4):1358-67. PubMed ID: 9751354
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of different drugs on the treatment of benign prostate hyperplasia].
    Li NC, Wu SL, Jin J, Qiu SP, Kong CZ, Song YS, Ye ZQ, Sun G, Sun YH, Sun YC, Wang XF, Na YQ.
    Zhonghua Wai Ke Za Zhi; 2007 Jul 15; 45(14):947-50. PubMed ID: 17961376
    [Abstract] [Full Text] [Related]

  • 12. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
    Pushkar' DIu, Kosko DV, Loran OB, Kan IaD, Sapozhnikov IM, Tevlin KP.
    Urol Nefrol (Mosk); 1995 Jul 15; (4):32-5. PubMed ID: 7571199
    [Abstract] [Full Text] [Related]

  • 13. Terazosin and doxazosin in the treatment of BPH: results of a randomized study with crossover in non-responders.
    Samli MM, Dincel C.
    Urol Int; 2004 Jul 15; 73(2):125-9. PubMed ID: 15331896
    [Abstract] [Full Text] [Related]

  • 14. A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.
    Bozlu M, Ulusoy E, Cayan S, Akbay E, Görür S, Akbay E.
    Scand J Urol Nephrol; 2004 Jul 15; 38(5):391-5. PubMed ID: 15764250
    [Abstract] [Full Text] [Related]

  • 15. Comparative evaluation of Prostina and terazosin in the treatment of benign prostatic hyperplasia.
    Dogra PN, Biswas NR, Ravi AK, Mani K, Kumar V.
    J Indian Med Assoc; 2005 Feb 15; 103(2):108-10, 112. PubMed ID: 16008322
    [Abstract] [Full Text] [Related]

  • 16. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.
    Johnson TM, Jones K, Williford WO, Kutner MH, Issa MM, Lepor H.
    J Urol; 2003 Jul 15; 170(1):145-8. PubMed ID: 12796667
    [Abstract] [Full Text] [Related]

  • 17. [A randomized comparative study assessing once versus twice a day treatment of benign prostatic hyperplasia with terazosin].
    Suzuki H, Ohnishi T, Ikemoto I, Ohishi Y, Suzuki Y, Yamazaki H.
    Hinyokika Kiyo; 2001 Feb 15; 47(2):77-81. PubMed ID: 11280890
    [Abstract] [Full Text] [Related]

  • 18. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
    Agha AH, Roy JB, Culkin DJ, Lyon K.
    Adv Ther; 1995 Feb 15; 12(6):361-6. PubMed ID: 10163332
    [Abstract] [Full Text] [Related]

  • 19. Terazosin vs finasteride for BPH.
    Zacks M.
    J Fam Pract; 1996 Dec 15; 43(6):533. PubMed ID: 8969692
    [No Abstract] [Full Text] [Related]

  • 20. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ, Miner M.
    Clin Ther; 2007 Jan 15; 29(1):17-25. PubMed ID: 17379044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.